Research Spotlight

Feb2018 AlzheimersInDs 637297080437914151 o6UI7E

Research Spotlight

Biogen Announces New Hope for Alzheimer’s Drug Candidate Aducanumab

On October 22, 2019, the biopharmaceutical company, Biogen, announced that they will be going to…

CapetivateOctober 22, 2019

UntitledProjectCapone2 Time0 45 2726 637297085067034243 kO9DUe

Research Spotlight

Clinicians Answer Additional Medical Questions From LuMind IDSC Research Rally Panel Q&A

The 2019 Research Rally Breakfast at the NDSC Annual Convention was attended by 400 families…

CapetivateAugust 8, 2019

shutterstock 49233463e1557766280712 637297088566294000 DD6pbC

Research Spotlight

LIFE-DSR Study – Why Natural History Studies Are Important on the Path to New Treatments

The LIFE DSR Study is the first investigation of the DS-CTN network. The study aims…

CapetivateMay 13, 2019

CerveauAnnouncement 637297104910251306 P0uv87

Research Spotlight

Cerveau Technologies, Inc. Announces Partnership with LuMind IDSC to Expand LIFE DSR Study

The LuMind IDSC Foundation is excited to welcome a new Research Partner to the community!…

CapetivateMay 9, 2019

DSCTNSquareImge1585678558302 637292170582486640 nXhQKP

Research Spotlight

LuMind Research Down Syndrome Foundation Launches the Down Syndrome Clinical Trials Network

BURLINGTON, Mass. , 2018 – With a combined $3M commitment from the Alana Foundation and…

CapetivateNovember 1, 2018

Rochee1467300126456 637292154087226555 TzmMY9

Research Spotlight

Published results on the Roche Clinical Trials for CLEMATIS expected in the first half of 2019

Many of you have asked LuMind RDS about the publishing of the results of the Hoffman-La Roche…

CapetivateJuly 5, 2018

Research Spotlight

New Trans-NIH INCLUDE Project for Down Syndrome will provide up to $261M Over 5 Years

MARLBOROUGH, MA. (June 22, 2018) — On Friday, June 21, The National Institute of Health (NIH)…

CapetivateJune 22, 2018

NIH Clinical Center South Entrance 75 resize 637292135432499802 MLPRQh

Research Spotlight

Historic ~65% increase for NIH Down syndrome research

Marlborough MA, May 27, 2017 — On Thursday this week, Congress’ House Labor and Health…

CapetivateMay 26, 2018

Research Spotlight

Increased Commitment to Down Syndrome Research Included in 2018 Omnibus Spending Bill

New trans-NIH Down Syndrome Initiative aims for scientific discoveries to improve the health and neurodevelopment…

CapetivateMarch 23, 2018

Biogen Announces New Hope for Alzheimer’s Drug Candidate Aducanumab

Clinicians Answer Additional Medical Questions From LuMind IDSC Research Rally Panel Q&A

LIFE-DSR Study – Why Natural History Studies Are Important on the Path to New Treatments

Cerveau Technologies, Inc. Announces Partnership with LuMind IDSC to Expand LIFE DSR Study

LuMind Research Down Syndrome Foundation Launches the Down Syndrome Clinical Trials Network

Published results on the Roche Clinical Trials for CLEMATIS expected in the first half of 2019

New Trans-NIH INCLUDE Project for Down Syndrome will provide up to $261M Over 5 Years

Historic ~65% increase for NIH Down syndrome research

Increased Commitment to Down Syndrome Research Included in 2018 Omnibus Spending Bill

Recent Posts

CONTACT LUMIND IDSC

QUICK LINKS

NEED MORE INFORMATION?